Biopharmaceutical Contract Manufacturers: Gearing Up for Increased Outsourcing.MORAGA, Calif.--(BW HealthWire)--Oct. 28, 1998--Outsourcing of biopharmaceutical manufacturing is gaining in popularity, whether or not a biotechnology or pharmaceutical company has in-house capability. Biotech companies need to be fast and flexible, and outsourcing is an important part of this flexibility. Some of the large pharmaceutical companies are making strategic shifts away from full integration, moving toward more outsourcing for lower costs, to gain access to expertise and capacity, or to shorten the time to market. Considering the unique requirements for the production of biopharmaceuticals and the cost of building and maintaining capacity, it is no wonder that outsourcing is becoming an important manufacturing strategy. Today, the majority of the biotechnology and pharmaceutical companies are outsourcing at least part of their analytical lab or manufacturing requirements. This year, an important collaboration was announced between Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. and the LONZA Group Lonza Group is a Swiss chemicals and biotechnology company, headquartered in Basel. The firm provides a number of products and services to the pharmaceutical and life science industries, including organic fine and performance chemicals, custom manufacturing of biopharmaceuticals, to develop and manufacture Activated Protein C (APC (1) (American Power Conversion Corporation, West Kingston, RI, www.apcc.com) The leading manufacturer of UPS systems and surge suppressors, founded in 1981 by Rodger Dowdell, Neil Rasmussen and Emanual Landsman, three electronic power engineers who had worked at MIT. ). Manufacturing proteins such as APC on a large scale can be complex and costly. The announcement from Eli Lilly Eli Lilly can refer to:
n.pl the costs that do not change to meet fluctuations in enrollment or in use of services (e.g., salaries, rent, business license fees, and depreciation). . DSM 1. DSM - Data Structure Manager. An object-oriented language by J.E. Rumbaugh and M.E. Loomis of GE, similar to C++. It is used in implementation of CAD/CAE software. DSM is written in DSM and C and produces C as output. Biologics and Megabios announced a partnership whereby DSM will manufacture DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. plasmids and lipid-DNA complexes using Megabios' proprietary manufacturing technology for the gene therapy industry. Boehringer Ingelheim Pharma KG recently announced it will manufacture a moncolonal antibody product for MedImmune. Covance is manufacturing a therapeutic, used following a stroke, that will soon enter clinical trials. To document the growing outsourcing market for biopharmaceutical manufacturing, HighTech Business Decisions is designing a comprehensive market research report on the industry. In-depth interviews with decision-makers from at least 40 pharmaceutical and biotechnology companies worldwide will be conducted by Ph.D. analysts. The report also will include profiles from more than 70 biopharmaceutical contract manufacturing suppliers providing a wide variety of manufacturing-related services, such as microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. fermentation and/or cell culture production with purification, process development, cell banking, virus production, analytical testing, biosafety testing, fill and finish including lyophilization lyophilization /ly·oph·i·li·za·tion/ (li-of?i-li-za´shun) the creation of a stable preparation of a biological substance by rapid freezing and dehydration of the frozen product under high vacuum. and formulation, labeling, storage and distribution. Contractors worldwide will be profiled. Companies that want to obtain this comprehensive and timely industry report at a shared cost per sponsor should call HighTech Business Decisions for details. HighTech Business Decisions is a market research and consulting firm serving clients in biotechnology and electronics markets. Sandra Fox, president, has ten years of experience providing clients with important information about customers and suppliers in these industries. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion